MedTrace Logo

Self-Affirmation and Defensiveness to Health Messages for the Self vs. a Close Other

NCT02317380 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1019

Last updated 2018-09-20

No results posted yet for this study

Summary

Background:

\- Researchers want to learn about people s beliefs and values. They also want to learn about how people respond to information about cancer risk. They have created two short studies. They have combined these studies for convenience.

Objective:

\- To learn about people s beliefs and values, and about how people respond to information about cancer risk.

Eligibility:

\- Adults age 40-70 who are overweight, have never had cancer, and have an opposite-sex close relationship with someone in that age group who is also overweight.

Design:

* This study will take place online or in a laboratory.
* Participants will take part in two studies. One is Values Study. The other is Cancer Risk Information.
* In Values Study, some participants will choose the most important value from a list. They will write about why that value is important to them. Others will choose the least important value from a list. They will write about why that value may be important to someone else.
* In Cancer Risk Information, participants will read a health message about a cancer risk relevant to themselves or to a close other. Some will wear special glasses that track their eye movements as they read.
* Participants will then answer questions about their beliefs about cancer risk and their intentions to lose weight.
* Both studies will take 30 minutes.

Conditions

  • Ego
  • Social Science
  • Cancer Prevention

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Rebecca A Ferrer, Ph.D. · National Cancer Institute (NCI)

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-12-13
Primary Completion
2015-11-10
Completion
2018-09-18

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02317380 on ClinicalTrials.gov